- Home
- VEEA vs CRBU Comparison
VEEA vs CRBU Comparison
Compare VEEA & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEA
- CRBU
- Stock Information
- Founded
- VEEA 2014
- CRBU 2011
- Country
- VEEA United States
- CRBU United States
- Employees
- VEEA N/A
- CRBU N/A
- Industry
- VEEA
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- VEEA
- CRBU Health Care
- Exchange
- VEEA NYSE
- CRBU Nasdaq
- Market Cap
- VEEA 112.2M
- CRBU 93.0M
- IPO Year
- VEEA N/A
- CRBU 2021
- Fundamental
- Price
- VEEA $2.07
- CRBU $0.97
- Analyst Decision
- VEEA
- CRBU Strong Buy
- Analyst Count
- VEEA 0
- CRBU 4
- Target Price
- VEEA N/A
- CRBU $8.50
- AVG Volume (30 Days)
- VEEA 46.5K
- CRBU 991.2K
- Earning Date
- VEEA 06-10-2025
- CRBU 05-08-2025
- Dividend Yield
- VEEA N/A
- CRBU N/A
- EPS Growth
- VEEA N/A
- CRBU N/A
- EPS
- VEEA N/A
- CRBU N/A
- Revenue
- VEEA $139,252.00
- CRBU $9,918,000.00
- Revenue This Year
- VEEA N/A
- CRBU N/A
- Revenue Next Year
- VEEA N/A
- CRBU $161.81
- P/E Ratio
- VEEA N/A
- CRBU N/A
- Revenue Growth
- VEEA N/A
- CRBU N/A
- 52 Week Low
- VEEA $1.33
- CRBU $0.66
- 52 Week High
- VEEA $18.56
- CRBU $3.00
- Technical
- Relative Strength Index (RSI)
- VEEA N/A
- CRBU 50.97
- Support Level
- VEEA N/A
- CRBU $0.98
- Resistance Level
- VEEA N/A
- CRBU $1.21
- Average True Range (ATR)
- VEEA 0.00
- CRBU 0.10
- MACD
- VEEA 0.00
- CRBU 0.01
- Stochastic Oscillator
- VEEA 0.00
- CRBU 46.69
About VEEA VEEA INC
Veea Inc is a company providing edge platform having extensive knowledge and expertise on content delivery and edge computing, and has brought a broad range of Wi-Fi, 4G/5G mobile wireless, and IoT products to market over the past two decades. It has first-in-class VeeaHub smart computing hubs integrate a full range of connectivity options, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.